12 Dec, 15:39 - Indian

SENSEX 81289.96 (-0.29)

Nifty 50 24548.7 (-0.38)

Nifty Bank 53216.45 (-0.33)

Nifty IT 45701.65 (0.77)

Nifty Midcap 100 59021.7 (-0.46)

Nifty Next 50 73082.6 (-0.29)

Nifty Pharma 22229.3 (-0.33)

Nifty Smallcap 100 19466.55 (-0.97)

12 Dec, 15:39 - Global

NIKKEI 225 39849.14 (1.21)

HANG SENG 20397.05 (1.20)

S&P 6094.5 (-0.17)

Login/Signup

You are Here : Home > Research

29-Oct-2024

Sun Pharmaceuticals Industries

OPM jumped by 356 bps

'On consolidated basis

Quarter ended September 2024 compared with Quarter ended September 2023.

Net sales (including other operating income) of Sun Pharmaceuticals Industries has increased 9.01% to Rs 13291.39 crore.  Operating profit margin has jumped from 26.08% to 29.64%, leading to 23.89% rise in operating profit to Rs 3,938.96 crore.  Raw material cost as a % of total sales (net of stock adjustments) decreased from 13.79% to 12.50%.   Purchase of finished goods cost fell from 8.34% to 6.67%.   Employee cost decreased from 19.58% to 18.90%.   Other expenses fell from 31.97% to 31.89%.   

Other income rose 20.57% to Rs 354 crore.  PBIDT rose 23.61% to Rs 4292.96 crore.  Provision for interest rose 40.33% to Rs 69.17 crore.  Loan funds rose to Rs 2,571.95 crore as of 30 September 2024 from Rs 1,928.23 crore as of 30 September 2023.  Inventories decline...



Pleaselogin & subscribe to view the full report.

More Reports
More Reports View Company Information